Clinical Trial Update: First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab plus apatinib versus chemotherapy plus bevacizumab as first-line treatment for advanced cervical cancer; current status un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Persistent Cervical Cancer
• Stage Ivb Cervical Cancer

Drugs mentioned

• Apatinib (apatinib)
• Bevacizumab (bevacizumab)
• Camrelizumab (camrelizumab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stage IVB Cervical Cancer, Recurrent Cervical Cancer | Phase 2 | Status: UNKNOWN